Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) - Total Assets
Based on the latest financial reports, Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) holds total assets worth CN¥5.55 Billion CNY (≈ $812.30 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore debt repayment capacity of Anhui Huaren Health Pharmaceutical Co. L to assess how comfortably operating cash covers total debt obligations.
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A - Total Assets Trend (2021–2025)
This chart illustrates how Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's total assets have evolved over time, based on quarterly financial data. See net assets of Anhui Huaren Health Pharmaceutical Co. L for net asset value and shareholders' equity analysis.
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A - Asset Composition Analysis
Current Asset Composition (December 2025)
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's total assets of CN¥5.55 Billion consist of 53.1% current assets and 46.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 17.4% |
| Accounts Receivable | CN¥565.83 Million | 10.3% |
| Inventory | CN¥1.05 Billion | 19.2% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥69.82 Million | 1.3% |
| Goodwill | CN¥1.28 Billion | 23.4% |
Asset Composition Trend (2021–2025)
This chart illustrates how Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 301408 stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's current assets represent 53.1% of total assets in 2025, a decrease from 56.5% in 2021.
- Cash Position: Cash and equivalents constituted 17.4% of total assets in 2025, up from 14.4% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 24.0% of total assets, an increase from 9.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 23.4% of total assets.
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Competitors by Total Assets
Key competitors of Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Raia Drogasil S.A
SA:RADL3
|
Brazil | R$25.58 Billion |
|
Yifeng Pharmacy
SHG:603939
|
China | CN¥26.07 Billion |
|
Luyan Pharma Co Ltd
SHE:002788
|
China | CN¥13.34 Billion |
|
Shanghai No1 Pharmacy Co Ltd
SHG:600833
|
China | CN¥1.99 Billion |
|
Ji Yao Holding Group Co Ltd
SHE:300108
|
China | CN¥1.43 Billion |
|
Dashenlin Pharm Grp Co Ltd
SHG:603233
|
China | CN¥26.83 Billion |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
China | CN¥9.83 Billion |
|
Empreendimentos Pague Menos S.A
SA:PGMN3
|
Brazil | R$9.81 Billion |
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.13 | 1.19 | 1.26 |
| Quick Ratio | 0.71 | 0.79 | 0.82 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥333.52 Million | CN¥435.37 Million | CN¥527.13 Million |
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A - Advanced Valuation Insights
This section examines the relationship between Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.87 |
| Latest Market Cap to Assets Ratio | 0.15 |
| Asset Growth Rate (YoY) | 13.7% |
| Total Assets | CN¥5.49 Billion |
| Market Capitalization | $827.67 Million USD |
Valuation Analysis
Below Book Valuation: The market values Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's assets below their book value (0.15x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's assets grew by 13.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2021–2025)
The table below shows the annual total assets of Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥5.49 Billion ≈ $803.12 Million |
+13.67% |
| 2024-12-31 | CN¥4.83 Billion ≈ $706.50 Million |
+4.69% |
| 2023-12-31 | CN¥4.61 Billion ≈ $674.84 Million |
+79.01% |
| 2022-12-31 | CN¥2.58 Billion ≈ $376.98 Million |
+30.70% |
| 2021-12-31 | CN¥1.97 Billion ≈ $288.43 Million |
-- |
About Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
Anhui Huaren Health Pharmaceutical Co., Ltd. operates in the medical and healthcare industry. It offers products for oral and throat, nourishing, heat-clearing, respiratory system, and gynecology, as well as provides vitamins and minerals, and detoxifying products. In addition, it provides supplements, and nutrition and health products. Anhui Huaren Health Pharmaceutical Co., Ltd. was founded in … Read more